Patel Anish (CIK 1967163) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Buy ELVN (20,000 shares), Sell ELVN (48,057 shares), Sell ELVN (243 shares), Sell ELVN (4,958 shares), Sell ELVN (1,705 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Buy | 20,000 | $0 |
| 2026-01-13 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 48,057 | $1.3M |
| 2026-01-13 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 243 | $6,926 |
| 2025-12-10 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 4,958 | $102,928 |
| 2025-12-10 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 1,705 | $37,135 |
| 2025-11-12 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,054 | $105,037 |
| 2025-11-12 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 613 | $10,997 |
| 2025-10-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,667 | $134,007 |
| 2025-09-10 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,667 | $134,940 |
| 2025-08-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,262 | $113,968 |
| 2025-08-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 405 | $7,667 |
| 2025-07-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,362 | $125,650 |
| 2025-07-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 305 | $6,310 |
| 2025-06-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,607 | $134,320 |
| 2025-06-11 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 60 | $1,270 |
| 2025-05-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 6,173 | $112,966 |
| 2025-05-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 390 | $7,566 |
| 2025-05-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 104 | $2,066 |
| 2025-04-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 3,756 | $66,894 |
| 2025-04-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 2,763 | $50,535 |
| 2025-04-09 | Enliven Therapeutics, Inc. (ELVN) | CHIEF OPERATING OFFICER | Sell | 148 | $2,852 |
来源：SEC Form 4 申报文件 · 截至 2026-02-17